Skip to content

biomarkers in Systemic Lupus Erythematosus

biomarkers in Systemic Lupus Erythematosus - biomarkers in Systemic Lupus Erythematosus

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON31156
Enrollment
200
Registered
2007-07-13
Start date
2007-09-15
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sle systemic lupus erythematosus

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Diagnosis of SLE according to the 1997 American College of Rheumatology (ACR) revised criteria for the classification of systemic lupus erythematosus criteria for classification of SLE (appendix 1). Age > 18 years. Written informed consent.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Main study parameters/endpoints: Construction of a biobank and database of clinical parameters to identify relevant bio-markers.

Secondary

MeasureTime frame
- Complement C4 polymorphism - Gene expression profiling

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)